Alibaba Health Suffers Scandal Over Improper Drug Fees

Alibaba Health Information Technology Ltd. is accused of charging Chinese drug companies improper fees, in an escalation of a scandal that emerged last week when the healthcare unit of Alibaba Group Holdings was reportedly to lose its exclusive operational rights of a national electronic drug monitoring system. In a Caixin Magazine article, Alibaba Health has […]

Visit for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Read the original article: China Money Network